moxifloxacin has been researched along with Liver Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Himeno, A; Isozaki, T; Kawaguchi, H; Suzuki, H; Suzuki, Y | 1 |
| Iannini, PB | 1 |
1 review(s) available for moxifloxacin and Liver Dysfunction
| Article | Year |
|---|---|
The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Cardiovascular Diseases; Fluoroquinolones; Glucose; Homeostasis; Humans; Kidney Diseases; Liver Diseases; Metabolic Diseases; Moxifloxacin; Population Groups; Quinolines; Risk Factors | 2007 |
1 other study(ies) available for moxifloxacin and Liver Dysfunction
| Article | Year |
|---|---|
Multiple liver cyst infection caused by Salmonella ajiobo in autosomal dominant polycystic kidney disease.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Cysts; Female; Fluoroquinolones; Humans; Liver Diseases; Meropenem; Moxifloxacin; Polycystic Kidney, Autosomal Dominant; Quinolines; Salmonella; Salmonella Infections; Thienamycins; Tomography, X-Ray Computed | 2013 |